Imperial College London
Alternate

ProfessorEricAlton

Faculty of Medicine, National Heart & Lung Institute

Chair in Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7929e.alton

 
 
//

Assistant

 

Miss Samia Soussi +44 (0)20 7594 7980

 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@book{Alton:2013:10.2217/9781780840963,
author = {Alton, EW and Davies, JC and Griesenbach, U},
doi = {10.2217/9781780840963},
title = {Foreword: Current & emerging pharmaceutical treatments for cystic fibrosis lung disease},
url = {http://dx.doi.org/10.2217/9781780840963},
year = {2013}
}
Download

RIS format (EndNote, RefMan)

TY  - BOOK
AB  - This book contains contributions on cystic fibrosis (CF) lung disease from leading international investigators. In eight chapters, they describe exciting progress in each of their respective fields, from pathogenesis through symptomatic treatments to addressing the basic defect. Each describes an iterative process in the best traditions of science; hypotheses being tested, rejected or improved. All of the authors have made major contributions to the cause of CF research and treatment over many years, and in this book the Editors have encouraged them to speculate and to be controversial where necessary, providing genuine insight through their experience and expertise.
AU  - Alton,EW
AU  - Davies,JC
AU  - Griesenbach,U
DO  - 10.2217/9781780840963
PY  - 2013///
SN  - 9781780841489
TI  - Foreword: Current & emerging pharmaceutical treatments for cystic fibrosis lung disease
UR  - http://dx.doi.org/10.2217/9781780840963
ER  -
Download